Combining method of detection and 70-gene signature for enhanced prognostication of breast cancer-Reference-Cited by-同舟云学术

Combining method of detection and 70-gene signature for enhanced prognostication of breast cancer

Published:2021-06-30 Issue:2 Volume:189 Page:399-410
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Lopes Cardozo J. M. N.^ORCID,Schmidt M. K.^ORCID,van ’t Veer L. J.^ORCID,Cardoso F.^ORCID,Poncet C.^ORCID,Rutgers E. J. T.^ORCID,Drukker C. A.^ORCID

Funder

European Organisation for Research and Treatment of Cancer

Netherlands Cancer Insitute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-021-06315-3.pdf

Reference32 articles.

1. Welch HG, Prorok PC, O’Malley AJ, Kramer BS (2016) Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med 375:1438–1447. https://doi.org/10.1056/NEJMoa1600249

2. Nagtegaal ID, Allgood PC, Duffy SW et al (2011) Prognosis and pathology of screen-detected carcinomas. Cancer 117:1360–1368. https://doi.org/10.1002/cncr.25613

3. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet (London, England) 365:1687–1717. https://doi.org/10.1016/S0140-6736(05)66544-0

4. Autier P, Boniol M, Koechlin A et al (2017) Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study. BMJ 359:j5224. https://doi.org/10.1136/bmj.j5224

5. Integraal kankercentrum Nederland (2018) Borstkanker in Nederland—Trends 1989–2017. https://iknl.nl/getmedia/e2abd7e5-c6e5-4398-842f-e91facd3d6bd/iknl_rapport-borstkanker-in-nederland-311018-int.pdf

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triple-negative breast cancer survival prediction: population-based research using the SEER database and an external validation cohort;Frontiers in Oncology;2024-06-10

2. Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival;Journal of Clinical Oncology;2023-04-01

3. Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study;Journal of Geriatric Oncology;2022-11

4. Firmas génicas en el cáncer de mama;Revista de Senología y Patología Mamaria;2022-07

5. Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial;Journal of Clinical Oncology;2022-04-20